Related Topics News -

     
 Detail   |   Print    Next page > 
     
《業績》聯康生物科技集團全年純利9,332.7萬元升12.7% 派末期息0.313仙
2026-03-30T  
聯康生物科技與溫醫大國家工程研究中心及溫州市甌海區人民政府戰略合作
2025-12-30T  
聯康生物科技授予科興6國家獨家商業化治療骨質疏鬆藥物博固泰權利
2025-09-12T  
《業績》聯康生物科技中期純利7,596萬元增12.7% 不派息
2025-08-29T  
聯康生物科技硫酸艾沙康唑膠囊上市申請獲受理
2025-07-18T  
聯康生物科技地誇磷索鈉滴眼液上市申請獲批
2025-05-21T  
《業績》聯康生物科技集團去年純利8,277萬元升16.8% 末期息0.277仙
2025-03-28T  
碧桂園去年廣清區域共交付近1.3萬套 100%按時交付
2025-01-24T  
聯康生物科技集團委任執董及首席營運官
2024-12-17T  
聯康生物科技重組膠原蛋白二類醫療器械獲批 肌顏態醫療美容產品上市
2024-12-02T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.